Literature DB >> 10807562

Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.

H A Barton1, H J Clewell.   

Abstract

Alternatives for developing chronic exposure limits for noncancer effects of trichloroethylene (TCE) were evaluated. These alternatives were organized within a framework for dose-response assessment--exposure:dosimetry (pharmacokinetics):mode of action (pharmacodynamics): response. This framework provides a consistent structure within which to make scientific judgments about available information, its interpretation, and use. These judgments occur in the selection of critical studies, internal dose metrics, pharmacokinetic models, approaches for interspecies extrapolation of pharmacodynamics, and uncertainty factors. Potentially limiting end points included developmental eye malformations, liver effects, immunotoxicity, and kidney toxicity from oral exposure and neurological, liver, and kidney effects by inhalation. Each end point was evaluated quantitatively using several methods. Default analyses used the traditional no-observed adverse effect level divided by uncertainty factors and the benchmark dose divided by uncertainty factors methods. Subsequently, mode-of-action and pharmacokinetic information were incorporated. Internal dose metrics were estimated using a physiologically based pharmacokinetic (PBPK) model for TCE and its major metabolites. This approach was notably useful with neurological and kidney toxicities. The human PBPK model provided estimates of human exposure doses for the internal dose metrics. Pharmacodynamic data or default assumptions were used for interspecies extrapolation. For liver and neurological effects, humans appear no more sensitive than rodents when internal dose metrics were considered. Therefore, the interspecies uncertainty factor was reduced, illustrating that uncertainty factors are a semiquantitative approach fitting into the organizational framework. Incorporation of pharmacokinetics and pharmacodynamics can result in values that differ significantly from those obtained with the default methods.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807562      PMCID: PMC1637754          DOI: 10.1289/ehp.00108s2323

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  90 in total

1.  Regulatory history and experimental support of uncertainty (safety) factors.

Authors:  M L Dourson; J F Stara
Journal:  Regul Toxicol Pharmacol       Date:  1983-09       Impact factor: 3.271

2.  Humoral and cell-mediated immune status in mice exposed to trichloroethylene in the drinking water.

Authors:  V M Sanders; A N Tucker; K L White; B M Kauffmann; P Hallett; R A Carchman; J F Borzelleca; A E Munson
Journal:  Toxicol Appl Pharmacol       Date:  1982-03-15       Impact factor: 4.219

3.  Toxicology of trichloroethylene in the mouse.

Authors:  A N Tucker; V M Sanders; D W Barnes; T J Bradshaw; K L White; L E Sain; J F Borzelleca; A E Munson
Journal:  Toxicol Appl Pharmacol       Date:  1982-03-15       Impact factor: 4.219

4.  Effects of trichloroethylene inhalation on acid phosphatase in rodent brain.

Authors:  P Kjellstrand; A Edström; M Bjerkemo; B Holmquist
Journal:  Toxicol Lett       Date:  1982-01       Impact factor: 4.372

5.  Effect of trichloroethylene on the exploratory and locomotor activity of rats exposed during development.

Authors:  D H Taylor; K E Lagory; D J Zaccaro; R J Pfohl; R D Laurie
Journal:  Sci Total Environ       Date:  1985-12       Impact factor: 7.963

6.  Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment.

Authors:  C R Elcombe
Journal:  Arch Toxicol Suppl       Date:  1985

7.  Effects of continuous trichloroethylene inhalation on different strains of mice.

Authors:  P Kjellstrand; B Holmquist; N Mandahl; M Bjerkemo
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1983-11

8.  Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: possible relevance to species differences in hepatocarcinogenicity.

Authors:  C R Elcombe; M S Rose; I S Pratt
Journal:  Toxicol Appl Pharmacol       Date:  1985-07       Impact factor: 4.219

9.  Trichloroethylene: long-lasting changes in the brain after rehabilitation.

Authors:  K G Haglid; C Briving; H A Hansson; L Rosengren; P Kjellstrand; D Stavron; U Swedin; A Wronski
Journal:  Neurotoxicology       Date:  1981-12       Impact factor: 4.294

10.  Humoral and cell-mediated immune status in mice exposed to chloral hydrate.

Authors:  B M Kauffmann; K L White; V M Sanders; K A Douglas; L E Sain; J F Borzelleca; A E Munson
Journal:  Environ Health Perspect       Date:  1982-04       Impact factor: 9.031

View more
  14 in total

1.  Structures of aminoacylase 3 in complex with acetylated substrates.

Authors:  Jennifer M Hsieh; Kirill Tsirulnikov; Michael R Sawaya; Nathaniel Magilnick; Natalia Abuladze; Ira Kurtz; Jeff Abramson; Alexander Pushkin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion.

Authors:  K Sandy Pang; Matthew R Durk
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-12-14       Impact factor: 2.745

3.  Interstrain differences in the liver effects of trichloroethylene in a multistrain panel of inbred mice.

Authors:  Blair U Bradford; Eric F Lock; Oksana Kosyk; Sungkyoon Kim; Takeki Uehara; David Harbourt; Michelle DeSimone; David W Threadgill; Volodymyr Tryndyak; Igor P Pogribny; Lisa Bleyle; Dennis R Koop; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2010-12-06       Impact factor: 4.849

4.  Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.

Authors:  Sungkyoon Kim; David Kim; Gary M Pollack; Leonard B Collins; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2009-05-03       Impact factor: 4.219

5.  Liquid chromatography electrospray ionization tandem mass spectrometry analysis method for simultaneous detection of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.

Authors:  Sungkyoon Kim; Leonard B Collins; Gunnar Boysen; James A Swenberg; Avram Gold; Louise M Ball; Blair U Bradford; Ivan Rusyn
Journal:  Toxicology       Date:  2009-06-21       Impact factor: 4.221

6.  A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment.

Authors:  Harvey J Clewell; Melvin E Andersen; Hugh A Barton
Journal:  Environ Health Perspect       Date:  2002-01       Impact factor: 9.031

Review 7.  Human variability and susceptibility to trichloroethylene.

Authors:  G M Pastino; W Y Yap; M Carroquino
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 8.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

Authors:  H J Clewell; P R Gentry; T R Covington; J M Gearhart
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

9.  Molecular mechanism of trichloroethylene-induced hepatotoxicity mediated by CYP2E1.

Authors:  Doni Hikmat Ramdhan; Michihiro Kamijima; Naoyasu Yamada; Yuki Ito; Yukie Yanagiba; Daichi Nakamura; Ai Okamura; Gaku Ichihara; Toshifumi Aoyama; Frank J Gonzalez; Tamie Nakajima
Journal:  Toxicol Appl Pharmacol       Date:  2008-05-02       Impact factor: 4.460

10.  In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane.

Authors:  Ivan D Dobrev; Melvin E Andersen; Raymond S H Yang
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.